Sensex gains for third day; Q3 earnings key
MUMBAI (Reuters) - BSE Sensex edgedup on Thursday, marking a third consecutive session of gains that pushed indexes to their highest close in two years, as expectations for better-than-expected quarterly earnings lifted technology stocks such as Infosys.
Shares have started 2013 on a strong note as investors bet the Reserve Bank of India (RBI) will cut interest rates later this month, and as the resolution to the so-called U.S. "fiscal cliff" negotiations have benefitted global markets.
Foreign investors have also bought a net 19.25 billion rupees in equities this year, according to provisional exchange and regulatory data, after buying a net $24.37 billion last year.
However, analysts say 2013 would be a lot different from 2012, which saw a 25.7 percent gain in the benchmark index, as budget problems in the U.S. are far from over, while at home the fiscal defict poses a challenge for a meaningful reduction in interest rates.
"Market is in a wait-and-watch mode because U.S. problems are just postponed and not solved as discussion regarding debt limit will come back," said Jagannadham Thunuguntla, head of Research at SMC Investmensts and Advisors.
Earnings growth in 2013 will largely depend on the central bank's stance on rates and government policy measures, he added.
The benchmark BSE index rose 0.26 percent, or 50.54 points, to end at 19,764.78, marking its highest close since January 6, 2011.
The broader NSE index rose 0.27 percent, or 16.25 points, to end at 6,009.50, its highest close since January 6, 2011, and ending above the psychologically key level of 6,000 points.
Indian companies are due to start reporting earnings next week, with Infosys Ltd (INFY.NS) kicking off on January 11.
Hopes that software service exporters would report solid earnings were amplified by expectations an agreement on the U.S. fiscal cliff would improve demand from the key U.S. market.
Infosys gained 1.24 percent, Tata Consultancy Services Ltd (TCS.NS) rose 1.4 percent, while Wipro Ltd (WIPR.NS) ended up 1 percent.
Jet Airways (JET.NS) gained 4.7 percent after a Indian government source told reporters the carrier was the front-runner for an investment from Etihad Airways.
Jet later confirmed it was in talks with Etihad, in the first confirmation of a potential deal by either side.
SpiceJet Ltd (SPJT.BO) gained 1 percent on hopes the carrier would also eventually attract foreign investment, but Kingfisher Airlines (KING.NS) fell 2.
India's Dr. Reddy's Laboratories Ltd (REDY.NS) gained 2.4 percent after the company said it has launched prostate drug finasteride tablets in the U.S.
Shares in gold loan providers rallied after a central bank report proposed increasing the loan-to-value, or LTV, ratio to 75 percent from 60 percent currently.
Muthoot Finance (MUTT.NS) shares ended up 9.7 percent, while Manappuram Finance (MNFL.NS) closed 20 percent higher at the maximun daily limit.
However, shares in Titan Industries (TITN.NS), which makes gold jewellery, ended down 1.75 percent on concerns over rising costs after the government said it will make importing gold costlier.
Shares in India's biggest domestic iron ore producer, state-run NMDC Ltd, (NMDC.NS) fell 3.22 percent after reducing prices for its most common grade by almost 6 percent a tonne in January, an unexpected move that will help cut the costs of steel makers who rely on imports.
(Additional reporting by Manoj Dharra; Editing by Sunil Nair)
- Tweet this
- Share this
- Digg this
- UPDATE 1-Boehner erupts at conservative groups ahead of U.S. budget vote
- South Africa admits error over 'schizophrenic' Mandela signer |
- Air strike kills 15 civilians in Yemen by mistake-officials
- UPDATE 2-Hilton Worldwide Holdings shares climb 9 percent in IPO
- UPDATE 2-Bangladesh executes Islamist leader, deadly clashes on streets
India's battle with inflation and weak economic growth became more challenging on Thursday with a sharp spike in the cost of food driving the highest retail price rises on record and a worse-than-anticipated contraction in industrial production. Full Article